Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study

被引：0
|
作者：
Li Ying
Ji Suyun
Liang Yanhua
Liang Yunsheng
Deng Li
Dang Lin
Lv Chengzhi
Lin Bingjiang
Zhang Furen
Shi Wendi
Li Jinnan
Dong Yu
Dou Guanshen
Yuling Shi
机构：
[1] Tongji University School of Medicine,Department of Dermatology, Shanghai Skin Disease Hospital
[2] Southern Medical University,Department of Dermatology, Dermatology Hospital
[3] Southern Medical University,Department of Dermatology, Cosmetology and Venereology, Shenzhen Hospital
[4] Longgang Central Hospital of Shenzhen,Department of Dermatology
[5] Dalian Skin Disease Hospital,Department of Dermatology
[6] Ningbo First Hospital,Department of Dermatology
[7] Shandong First Medical University & Shandong Academy of Medical Sciences,Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology
[8] Eli Lilly and Company,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Efficacy; Ixekizumab; Psoriasis; Real world; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5464 / 5474
页数：10
相关论文
共 50 条
  • [41] Safety and efficacy of etanercept monotherapy for moderate-to-severe plaque psoriasis: A prospective 12-week follow-up study
    Xie, Fang
    Wang, Rui
    Zhao, Zi-gang
    Meng, Xian-fu
    Lin, Bi-wen
    Yang, Jie
    Wang, Wen-juan
    Ding, Xiang-yu
    Yang, Yi
    Zhao, Hua
    Li, Cheng-xin
    Li, Heng-jin
    Zhou, Yong
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2017, 37 (06) : 943 - 947
  • [42] Efficacy and safety of ixekizumab (IXE) compared to ustekinumab (UST) in patients with moderate-to-severe plaque psoriasis: A randomised head-to-head trial
    Burkhardt, N.
    Reich, K.
    Lomaga, M.
    Henneges, C.
    Dossenbach, M.
    Wilhelm, S.
    Paul, C.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 : 43 - 43
  • [43] Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy
    Giunta, Alessandro
    Ventura, Alessandra
    Chimenti, Maria Sole
    Bianchi, Luca
    Esposito, Maria
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1643 - 1651
  • [44] Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort study
    Lytvyn, Yuliya
    Mufti, Asfandyar
    Zaaroura, Hiba
    Sachdeva, Muskaan
    Lu, Justin D.
    Rankin, Brian D.
    Prajapati, Vimal H.
    Vender, Ronald
    Yeung, Jensen
    JAAD INTERNATIONAL, 2022, 6 : 3 - 5
  • [45] Efficacy and safety of etanercept in moderate to severe plaque psoriasis
    Tunca, M.
    Koc, E.
    Akar, A.
    Kurumlu, Z.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 : 53 - 53
  • [46] Risankizumab in moderate-to-severe plaque psoriasis
    Serrano, Linda
    Maloney, Victoria
    Gordon, Kenneth B.
    IMMUNOTHERAPY, 2019, 11 (16) : 1357 - 1370
  • [47] Efficacy and safety of secukinumab in moderate to severe plaque psoriasis
    Aparicio Rubio, Celia
    Monteagudo Santolaya, Emilio
    Cornejo Uixeda, Silvia
    Prieto Castello, Manuel
    Antonino de la Camara, Gonzalo
    Quintana Vergara, Belen
    Sanchez Alcaraz, Agustin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 299 - 299
  • [48] Efficacy and safety of systemic treatments for moderate-to-severe psoriasis
    Anstey, Alex
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (02)
  • [49] Treatment of moderate-to-severe plaque psoriasis
    Salgo, R.
    Thaci, D.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06): : 701 - 711
  • [50] Tildrakizumab in moderate-to-severe plaque psoriasis: A multicenter, retrospective, real-life study
    Caldarola, Giacomo
    Galluzzo, Marco
    Bernardini, Nicoletta
    Calabrese, Laura
    Grimaldi, Marta
    Moretta, Gaia
    Pagnanelli, Gianluca
    Shumak, Ruslana Gaeta
    Talamonti, Marina
    Tofani, Lorenzo
    Pallotta, Sabatino
    Peris, Ketty
    Potenza, Concetta
    De Simone, Clara
    Campione, Elena
    DERMATOLOGIC THERAPY, 2022, 35 (06)
12345